£10M bioincubator opens on the Babraham Research CampusThe newest building on the Babraham Research Campus, the Bennet Building, was officially opened today by Dr Menelas Pangalos, Executive President at Astra Zeneca. The £10M building is part of a £44M development programme funded by BBSRC to expand and support commercial life science enterprises on the campus.
The building is already fully let to two tenants: Kymab, which develops new antibody medicines, and Eagle Genomics, providing bioinformatics services and management of genomic data. The Babraham Institute and Eagle Genomics work collaboratively through a training grant (BBSRC CASE studentship) and Kymab uses the Institute’s world-leading scientific facilities.
Babraham Institute Director, Professor Michael Wakelam, said: “We’re proud to be a part of the flourishing bioscience ecosystem in the Cambridge region and look forward to further developing our relationships with Kymab and Eagle Genomics. Sharing the research excellence and facilities of the Babraham Institute with our campus neighbours benefits us all by promoting innovation across the academic and commercial bioscience sectors.”
Derek Jones, Chief Executive of Babraham Bioscience Technologies, the Babraham Institute’s subsidiary company, said: “With around sixty companies at the Babraham Research Campus, we continue to be an important regional centre for commercial life science research.
“Co-location of world-class academic research carried out at the Babraham Institute, with early-stage and growing life science companies benefits both the academic science and the companies themselves, whether that is access to expertise and facilities, or the community that exists here.”
Related links:BBSRC news release: Cutting-edge bioscience building opens to develop businesses
19 January, 2015